Recent Articles

3 Biotech Stocks That Belong in Your Portfolio

The recent pullback in biotech stocks is an opportunity for investors to appeal to both growth and value in this dynamic sector. More 

Dow Theory Buy Signal Confirmed

The industrials broke to a new closing high, putting the pressure on the bears. More 

2 Clear Signs That Biotechs and Pharmaceuticals Have Peaked

Pharmaceuticals and biotechs have been too hot for their own good, fueled by increasingly iffy M&A and an oddly high level of IPO activity. More 

3 Biotech Stocks That Could Keep Bombing

After years of unchecked rallying in biotech stocks, a correction is finally upon us. And as bad as things have been, the mean-reversion move could go even lower. More 

MNKD Stock, Take Two: Volatility or Not, You Have to Like Afrezza

Unfortunately, a bet on MNKD stock right now isn't a bet on the potential of Afrezza. But sooner or later, these facts will be reflected in MannKind shares. More 

MNKD: Buy the Rumor, Sell the News

MannKind has much to be excited about today with Afrezza, but investors need to recognize a troubling pattern that could upend MNKD stock. More 

Ready, Aim, Bargain Hunt

Those with a good risk tolerance should use the current weakness to buy high-quality, oversold stocks. More